SARS‐CoV‐2 infection during pregnancy is associated with adverse maternal and neonatal
outcomes, but no systematic synthesis of evidence on COVID‐19 vaccination during …

Data on the safety of COVID-19 vaccines in early pregnancy are limited. We conducted a
national, population-based, matched cohort study assessing associations between COVID …

Abstract SARS‐CoV‐2, the etiological agent of COVID-19, is devoid of any metabolic
capacity; therefore, it is critical for the viral pathogen to hijack host cellular metabolic …

Studies observed that women infected with SARS-CoV-2 during pregnancy had a higher risk
of preterm birth. Although it is likely that COVID-19 during the late trimester of pregnancy can …

Background Stillbirth has been recognized as a possible complication of a SARS-CoV-2
infection during pregnancy, probably due to destructive placental lesions (SARS-CoV-2 …

Ferroptosis, a regulated non-apoptotic form of cell death, has been implicated in the
response to varied types of infectious agents including virus. In this study, we sought to …

BACKGROUND Pregnant women infected with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are more likely to experience preterm birth and their neonates …

Associations between antenatal SARS-CoV-2 infection and pregnancy outcomes have been
conflicting and the role of the immune system is currently unclear. This prospective cohort …

Background The influence of SARS-CoV-2 infection after embryo transfer on early
pregnancy outcomes in in vitro fertilization or intracytoplasmic sperm injection–embryo …

It is assumed that SARS-CoV-2-and COVID-19-associated autoimmune processes may
affect the outcomes of assisted reproductive technology (ART) cycles. This observational …